Canonical Wnt signaling has been implicated in various aspects of hematopoiesis. Its role is controversial due to different outcomes between various inducible Wnt-signaling loss-of-function models and also compared with gain-of-function systems. We therefore studied a mouse deficient for a Wnt gene that seemed to play a nonredundant role in hematopoiesis. Mice lacking Wnt3a die prenatally around embryonic day (E) 12.5, allowing fetal hematopoiesis to be studied using in vitro assays and transplantation into irradiated recipient mice. Here we show that Wnt3a deficiency leads to a reduction in the numbers of hematopoietic stem cells (HSCs) and progenitor cells in the fetal liver (FL) and to severely reduced reconstitution capacity as measured in secondary transplantation assays. This deficiency is irreversible and cannot be restored by transplantation into Wnt3a competent mice. The impaired long-term repopulation capacity of Wnt3a−/− HSCs could not be explained by altered cell cycle or survival of primitive progenitors. Moreover, Wnt3a deficiency affected myeloid but not B-lymphoid development at the progenitor level, and affected immature thymocyte differentiation. Our results show that Wnt3a signaling not only provides proliferative stimuli, such as for immature thymocytes, but also regulates cell fate decisions of HSC during hematopoiesis.
Hematopoietic stem cells (HSCs) are responsible for the continuous production of blood cells and consequently help to sustain immune function. This is achieved by their unique capacity to self-renew and ability to differentiate into all blood lineages. Several studies have implicated the Wnt-signaling pathway in the regulation of these processes, but its exact role is still not completely understood.1,2
Upon binding of a Wnt protein to a Frizzled receptor and to a LRP5/6 coreceptor, an elaborate signaling route leads to cytoplasmatic accumulation and subsequent nuclear translocation of β-catenin, the key mediator of the Wnt-signaling pathway. In the absence of a Wnt protein, the levels of β-catenin are kept very low by the action of the so-called destruction complex consisting of the casein kinase I (CKI) and glycogen synthase kinase 3β (GSK-3β) serine/threonine kinases, the tumor suppressor protein adenomatous polyposis coli (APC) and the scaffolding protein Axin. Phosphorylation of β-catenin by CKI and GSK-3β leads to its ubiquitination and subsequent breakdown in the proteossome. Activation of the Wnt pathway by a Wnt ligand results in inactivation of GSK-3β and consequent translocation of β-catenin to the nucleus. In the nucleus, β-catenin binds to members of the Tcf/Lef transcription factors family, thereby converting these proteins from transcriptional repressors into transcriptional activators.3
The first evidence for a role of Wnt proteins in hematopoiesis was reported in studies showing that stromal cell lines transduced with Wnt1, Wnt5a, and Wnt10b have an in vitro stimulatory effect on mouse4 and human5 hematopoietic progenitors.
Using Tcf1/Lef-GFP reporter assays, Wnt signaling was shown to be active in the highly HSCs enriched Lin−Sca1+c-Kit+ (LSK) population, both in vivo as well as in vitro after stimulation with purified Wnt3a.6 Furthermore, Wnt3a treatment in vitro resulted in increased proliferation of LSK cells along with the maintenance of an immature phenotype and led to increased self-renewal as determined by transplantation assays.7 Retroviral expression of a constitutively active form of β-catenin in Bcl2-transgenic LSK cells resulted in augmented multilineage repopulation capacity. In agreement, ectopic expression of the Wnt-signaling inhibitor Axin yielded opposite results.6 However, subsequent gain- and loss-of-function approaches to further elucidate the role of Wnt signaling in HSCs yielded contradictory results. Two independent studies using a conditional mouse model to express a stabilized form of β-catenin showed impaired multilineage differentiation and a transient increase in stem cell numbers, followed by exhaustion of the HSC pool, observed by failure to repopulate lethally irradiated recipients.8,9 Therefore, the role of Wnt signaling in HSC biology is currently controversial. Besides this, reciprocal approaches to conditionally inactivate β-catenin in HSCs also showed contradictory results and brought further controversy, with some of these studies showing normal hematopoiesis and stem cell activity in the combined absence of β-catenin and its homologue plakoglobin.10-13 These issues are reviewed in more detail elsewhere.14
The functions of several Wnt genes have been investigated by targeted mutations in the mouse. These led to specific developmental defects, which are lethal early during embryonic development or shortly after birth. Mice carrying a null allele of Wnt3a have been generated by McMahon and coworkers. Wnt3a homozygous mutant embryos die around embryonic day (E) 12.5 of the embryonic development. These embryos lack caudal somites, have disrupted notochords and exhibit anomalies of the central nervous system.15 The hematopoietic system of these embryos has not been studied yet. However, the fact that Wnt3a promotes proliferation of HSCs7 and pro-B cells,16 and the high expression in the thymic stroma17 make the Wnt3a gene of interest. In addition, Wnt3a−/− embryos are morphologically highly similar to Tcf1/Lef1 double-deficient embryos,18,19 suggesting comparable defects in the hematopoietic system20 of both strains. For these reasons we decided to investigate the hematopoietic system of Wnt3a−/− embryos.
Here we demonstrate that Wnt3a deficiency leads to a reduction in the numbers of hematopoietic stem and progenitor cells in the fetal liver (FL). Besides this, HSCs are functionally affected as purified LSK cells show severely reduced reconstitution capacity measured by secondary transplantation assays. This deficiency is irreversible since transplantation into wild-type (Wt) recipient mice could not restore HSC function, suggesting a role for Wnt3a in the establishment of a HSC-specific genetic program. Moreover Wnt3a deficiency affected myeloid but not lymphoid development at the progenitor level and early stages of T-lymphoid development in the thymus.
Our data provide genetic evidence for the involvement of a specific Wnt protein in HSC self-renewal, suggesting that modulation of Wnt signaling in stem cells or in their environment may be beneficial for stem cell therapies, transplantation, and regenerative medicine applications (Wilmington, MA).
Wnt3a heterozygous mice were bred and maintained in the Erasmus Medical Center animal facility, in accordance with the legal regulations in The Netherlands and with the approval of the Dutch animal ethical committee, the DEC.
Mice heterozygous for the Wnt3a mutation were kindly provided by T. Yamaguchi (National Cancer Institute-Frederick, Frederick, MD) and were backcrossed to C57Bl/6. Genotyping was performed as described.15 To obtain Wnt3a−/− embryos, Wnt3a heterozygous mice were put together in the afternoon and checked for vaginal plug the next morning. The time at which the vaginal plug was observed was considered E0.5. Embryos were analyzed at E12.5. C57Bl/6-Ly5.1 mice were purchased from Charles River Laboratories (Wilmington, MA).
Flow cytometry and cell sorting
For flow cytometric analyses and cell sorting, cells were stained with monoclonal antibodies against the following molecules: B220 (Ra3-6B2), CD3 (145-2C11), CD4 (L3T4), CD8 (53-6.7), CD11b/Mac1 (M1/70), CD11c (HL3), CD19 (ID3), CD43 (S7), CD45.1/Ly5.1 (A20), CD45.2/Ly5.2,(104) CD71 (C2), CD117/c-Kit (2B8), CD127/IL-7Rα (SB/199), CD135/Flt3 (A2F10.1), F4/80 (BM8), GR1 (RB6-8C5), IgM (R6-60.2), NK1.1 (PK136), Sca1 (E13-161.7) and Ter-119 all from Becton Dickinson/Pharmingen (San Jose, CA); CD34 (RAM34) and FcγRII/III(93) from eBioscience (San Diego, CA); activated Notch1 (mN1A) from Abcam (Cambridge, MA). Antibodies were used either directly conjugated or biotinylated. For secondary detection streptavidin conjugated with PE-Cy7 or APC-Cy7 was used. 7AAD (Pharmingen) or DAPI (Invitrogen, Carlsbad, CA)) were used for dead cells exclusion. Stained cells were measured with a FACSCalibur and/or a FACSCanto, sorted on a FACSAria (Becton Dickinson), and analyzed with FlowJo software (TreeStar, Ashland, OR). To analyze LSK in FL, antibodies for lineage markers included B220, CD4, CD11c, GR1, NK1.1 and Ter-119. When LSKs were analyzed in adult bone marrow (BM) antibodies against CD11b (Mac1) and CD3 were added to the lineage mix.
Cell cycle and apoptosis
Cell-cycle analysis of FL stem and progenitor cells was performed by staining for 60 minutes 37°C with Hoechst 33342 ((Invitrogen/Molecular Probes, Carlsbad, CA; 10 μg/mL) in DMEM medium supplemented with Verapamil inhibitor (Sigma-Aldrich, St Louis, MO; 10 μM), 2% FBS and 1 mM HEPES (Invitrogen). Hoechst 33342 stained cells were than stained with flow cytometry antibodies. To analyze the percentage of apoptotic cells by flow cytometry, FL cells were stained with markers to define the LSK population (see “Flow cytometry and cell sorting”) and subsequently stained with FITC-conjugated annexin V and 7AAD (Becton Dickinson/Pharmingen) according to the manufacturer's instructions.
For competitive transplantation assays, C57Bl/6 Ly5.1 recipient mice (8-11 weeks old) were lethally irradiated (9.5 Gy). Four hundred sorted LSKs (Ly5.2) from Wt or Wnt3a−/− E12.5 FLs were mixed with 2.5 × 105 total Ly5.1 FL cells (E12.5) to obtain 1:1 competition and intravenously injected in recipient mice. Repopulation, calculated as (percentage donor cells) × 100 / (percentage donor cells + percentage recipient cells), was evaluated at 4, 8, 10, and 12 weeks after transplantation in peripheral blood by flow cytometry. The mice were killed 12 weeks after transplantation. For secondary transplantation, equal numbers of total BM cells from primary recipients that received Wt or Wnt3a−/− LSKs were pooled and transplanted into lethally irradiated Ly5.1 secondary recipients. Peripheral blood from secondary transplanted mice was analyzed at 4, 8, and 12 weeks after transplantation. Thirteen weeks after transplantation, mice were killed and analyzed for reconstitution in BM, thymus, and spleen.
In vitro methylcellulose colony assays
For methylcellulose colony assays, FL cell suspensions were prepared in Iscove modified Dulbecco medium (IMDM) supplemented with 2% FBS. CFU-C and CFU-E assays were performed with MethoCult M3434 (containing rmSCF 50 ng/mL, rmIL-3 10 ng/mL, rhIL-6 10 ng/mL, and rhEPO 3 U/mL) or M3334 (containing rhEPO 3 U/mL), respectively, (from StemCell Technologies, Grenoble, France) in 35-mm dishes accordingly to manufacturer's instructions. All assays were done in triplicate. Colonies (> 30 cells) were counted after 7 days (CFU-C) or 3 days (CFU-E) of incubation at 37°C, 5% CO2 and humidified atmosphere. CFU-Mix were defined as colonies containing at least 3 different cell types. May-Grunwald Giemsa stainings were performed to confirm identification of the colonies by morphology.
Cocultures of FL cells with OP9 bone marrow stromal cell line
Total FL cells were cultured in RPMI-1640 medium supplemented with 10% FBS, mrIL-7 (10 ng/mL) and mrSCF (50 ng/mL; both from R&D Systems, Minneapolis, MN), for 24 hours to separate FL stroma from hematopoietic cells. Ten thousand to 50 000 cells were then cultured on confluent layers of the OP9 BM stromal cell line in αMEM medium, also supplemented with FBS, mrIL-7, and mrSCF. After 7 to 16 days of incubation at 37°C, cells were harvested and stained for flow cytometry.
Histology and immunohistochemistry
Six-μm tissue sections of frozen E12.5 embryos were fixed in acetone. For visualization of the different organ structures, sections were stained with hematoxylin-eosin (HE). To envisage thymic epithelium, sections were incubated with concentrated supernatant from a hybridoma producing the ER-TR4 antibody for thymic stromal cells, followed by a biotinylated rabbit anti-rat antibody (Dako, Glostrup, Denmark) and finally with avidin-biotin complex–horseradish peroxidase (Dako). Sections were incubated with 3-amino-9-ethylcarbazole (AEC) substrate (Dako) to detect peroxidase.
Fetal thymic organ culture
Fetal thymic lobes from Wt and Wnt3a−/− E12.5 embryos were isolated and cultured on the top of a filter floating on medium (IMDM, 10% FBS). After 9 to 17 days of culture, cells were harvested and analyzed by flow cytometry.
Reduced numbers of HSCs in Wnt3a−/− E12.5 embryos
The loss of Wnt3a leads to embryonic lethality around E12.5. Wnt3a−/− embryos harbor a severe phenotype with little or no caudal development posterior to forelimbs, disrupted notochord, and abnormal formation of ectopic neural tubes.15 After E12.5, recovery of viable Wnt3a−/− embryos dramatically decreases, and therefore heterozygous mice were bred and the embryos analyzed at this age.
At E12.5 the FL is the major hematopoietic organ, which is colonized by progenitors from aorta-gonad-mesonephros (AGM) region, yolk sac and placenta, starting by late E9.21 The FLs from Wnt3a−/− and Wt embryos did not differ in the total cell numbers (2.86 × 106 ± 1.28 × 106 in Wnt3a−/− and 3.32 × 106 ± 1.25 × 106 in Wt FLs; p = .54) and the total percentage of leukocytes (as determined by CD45 expression) did also not differ between Wt and Wnt3a−/− FLs (data not shown). Besides this, FLs were red, suggesting that the embryos were not anemic.
Murine HSCs are found in a rare population characterized by the absence of lineage markers and expression of Sca1 and c-Kit, the so-called LSKs (Lin− Sca1+ c-Kit+).22 Analysis of this population in the FLs from Wnt3a−/− embryos showed a marked reduction in the percentage of these cells (3- to 5-fold) comparing to Wt (Figure 1A,B). While in agreement with previous reports the Wt FLs contained 0.51% LSK, the Wnt3a−/− FLs contained only 0.15% LSKs on average.
Different studies have shown that up-regulation of Flt3/Flk2 expression is accompanied by loss of HSC long-term reconstitution capacity in BM and FL.23-25 The analysis of the Flt3− (HSCs) and Flt3+ (multipotent progenitors; MPP) subsets within the LSK population revealed that, although the Flt3+ subset was more severely affected, both populations were strongly decreased indicating a HSC deficiency (Figure 1C,D). This quantitative difference led to a difference in actual stem cell–dependent repopulation of recipient mice. That is, when different numbers of E12.5 FL cells from Wt or Wnt3a−/− embryos were transplanted into sublethally irradiated recipients (6Gy), only the highest number of Wnt3a−/− cells (4 × 106) could repopulate (> 1% donor contribution in peripheral blood) 3 of 3 recipient mice. By contrast, a 16-fold lower number of Wt cells transplanted (0.25 × 106 cells) was able to repopulate 2 of 6 recipient mice (Table 1), while none of the mice (0 of 6) that received Wnt3a−/− cells showed donor-derived reconstitution.
|E12.5 FL cells/mouse||Repopulated mice|
|0.25 × 106||2/6* (33%)†||0/6 (0%)|
|1 × 106||3/5 (60%)||0/3 (0%)|
|4 × 106||4/4 (100%)||3/3 (100%)|
|E12.5 FL cells/mouse||Repopulated mice|
|0.25 × 106||2/6* (33%)†||0/6 (0%)|
|1 × 106||3/5 (60%)||0/3 (0%)|
|4 × 106||4/4 (100%)||3/3 (100%)|
Multilineage repopulation was confirmed by flow cytometry for all repopulated animals.
Number of repopulated mice (> 1% in peripheral blood) 12 weeks after transplantation per total number of mice receiving a transplantation.
Correspondent frequencies of repopulated animals.
HSC self-renewal is irreversibly impaired
To test whether besides a severe quantitative reduction in HSC, these cells were also affected in their function, we performed competitive transplantation assays. For this, 400 LSKs isolated by cell sorting from Wt or Wnt3a−/− FLs (Ly5.2) were mixed with 2.5 × 105 Wt total FL cells (Ly5.1), which were measured to also contain around 400 LSK, to have an approximately 1:1 competition. The cell mixtures were intravenously injected into Wt Ly5.1 recipient mice that were lethally irradiated. The chimerism was followed in peripheral blood at 4, 8, 10, and 12 weeks after transplantation. Both Wt and Wnt3a−/− cells were able to repopulate the primary recipients with comparable efficiency (7 of 8 mice repopulated > 1% with Wt cells and 3/4 mice repopulated with Wnt3a−/− cells; Figure 2A). Besides this, 12 weeks after the beginning of the experiment, the analysis of BM of repopulated mice showed no significant difference in the percentage of total Ly5.2 (Figure 2B,C) and in the contribution toward the different lineages (data not shown). Analysis of the HSC compartment revealed a nonstatistically significant reduction in the frequency of Ly5.2 LSKs in the BM of mice receiving Wnt3a−/− cells (Figure 2D). Flt3− and Flt3+ subsets within LSK compartment did not differ between the mice receiving Wt or Wnt3a−/− LSKs (data not shown).
However, when total BM cells from the primary recipient mice were retransplanted into lethally irradiated Wt secondary recipients, the repopulation capacity measured in peripheral blood was severely reduced in mice receiving Wnt3a−/− cells, as early as 4 weeks after transplantation (Figure 3A). Furthermore, the contribution toward different lineages was strongly affected in the secondary recipients receiving Wnt3a−/− cells (Figure 3B). Analysis of the repopulation efficiency in BM 13 weeks after transplantation showed an average contribution of 60% in the mice that received retransplanted Wt cells whereas in the mice receiving retransplanted Wnt3a−/− cells this was reduced more than 15-fold (4% chimerism on average; Figure 3C,D). Moreover, although the total percentage of LSKs did not differ in the mice receiving Wnt3a−/− cells, this population mainly consisted of cells expressing the congenic marker Ly5.1, while around 70% (average) of the LSKs from the Wt mice group expressed the Ly5.2 marker (Figure 3E,F). The analysis performed in other hematopoietic organs such as thymus and spleen showed similar differences (data not shown). Thus, secondary transplantations revealed strongly reduced reconstitution by Wnt3a−/− HSCs, showing that these cells have extremely limited self-renewal capacity. Importantly, although being transplanted into Wt recipient mice, in which Wnt3a is abundantly expressed in BM,16 the LSK cells had very low repopulation efficiency, indicating a permanent and irreversible self-renewal deficiency.
Wnt3a−/− HSC have normal differentiation capacity
At E12.5, FL hematopoiesis is mainly directed toward erythrocyte production, with around 95% of the cells constituting erythroid progenitors. Analysis of the different stages of erythroid development using the erythroid-specific marker Ter119 and the transferrin receptor CD7126 together with the progenitor marker c-Kit, showed no significant differences between Wt and Wnt3a−/− FLs, indicating normal erythroid development (data not shown). Analysis of the nonerythroid lineages (CD71−Ter119−) showed that in the Wnt3a−/− livers the B220+ cells were also present in a similar frequency as in Wt embryos. However, total CD11b+ myeloid cells were slightly reduced (P = .01) in the livers from Wnt3a−/− embryos (Figure 4A,B). Nevertheless this reduction was not observed in the more mature CD11b+F4/80+ subset of myeloid cells, but it was due to a marked reduction in more immature CD11b+F4/80− myeloid cells (Figure 4A,B), suggesting a progenitor deficiency that does not impair terminal differentiation.
Reduced numbers of myeloid but not B-lymphoid progenitors
The decreased frequency of more immature myeloid cells, together with the strong reduction of MPPs indicated that Wnt3a deficiency is affecting not only HSC self-renewal but also primitive progenitors subsets.
To further investigate a possible deficiency in myeloid progenitors, in vitro methylcellulose colony-forming assays were performed. Interestingly, in the presence of multiple cytokines, compared with wild-type cells, the Wnt3a−/− FL cells consistently yielded > 3-fold fewer colonies (Figure 4C). Of interest, the relative frequency of the different types of colonies was also different between the Wt and Wnt3a−/− cells (Figure 4D). Wnt3a−/− FL cells yielded a lower number of CFU-Mix leading to a 6-fold reduction in the absolute numbers of these colonies. Besides this, also CFU-GM and BFU-E colonies appeared slightly reduced. In agreement with what was previously observed, absolute numbers of CFU-G and -M were not significantly different, indicating that more mature myeloid cells were produced at normal frequencies. Total number of CFU-E colonies was not significantly altered (Figure 4E). This was confirmed by flow cytometric analysis of the different myeloid progenitor subsets.27 Both common myeloid progenitors (CMPs; FcγRloCD34+) and granulocyte-monocyte-progenitors (GMPs; FcγRhiCD34+) frequencies in Wnt3a−/− FLs were severely reduced. Megakaryocyte-erythrocyte progenitors (MEPs; FcγRloCD34−) were not affected (Figure 4F,G).
Wnt3a has been proposed to function as a growth factor for pro-B cells when provided as a prototype Wnt in vitro.16 Moreover, the severe reduction in the numbers of MPPs suggested that Wnt3a−/− primitive progenitors might have reduced lymphoid potential.
Surprisingly, the analysis of the FL counterpart of adult common lymphoid progenitor (CLP), which is phenotypically similar (Lin−IL-7R+c-KitloSca1lo) and is present as a distinct population at E12.5,28 did not reveal any difference between Wt and Wnt3a−/− FLs, although there is a nonsignificant trend toward lower numbers of CLP in Wnt3a−/− embryos (Figure 5A,B). Furthermore, after 7 days of culture on OP9 BM-derived stromal cells, both Wt or Wnt3a−/− E12.5 FL cells efficiently developed into CD19+ B-cell progenitors (Figure 5C). Most cells were in the pro–B-cell stage, but after prolonged culturing intracellular IgM could be detected both in the cultures using Wt or Wnt3a−/− cells (data not shown). After 7 days of culturing, the percentage of CD19+ cells was significantly higher in the Wnt3a−/− cultures, but this increase was not reflected by an absolute increase in cell numbers. Rather it was attributed to the marked reduction of the CD11b+ population, confirming that Wnt3a deficiency negatively affects myeloid differentiation.
We were also interested in the capacity of Wnt3a−/− progenitors to seed the thymus and differentiate into the T-cell lineage. In the developing mouse embryo, the thymic rudiment is first colonized by immature cells at approximately E11.21 Because thymic lobes at E12.5 are not yet well-defined structures, sections were prepared and stained with HE to visualize different tissues. Presence of a thymic rudiment could be demonstrated in Wnt3a−/− embryos and was confirmed by staining with ER-TR4, which identifies thymic epithelial cells29 (Figure 5D). Although the thymic rudiment is seeded by hematopoietic cells, in Wnt3a−/− embryos it shows a noticeable reduction in size indicating that T-cell development is affected with respect to cell numbers. To further characterize this deficiency, explant cultures of E12.5 thymic lobes (fetal thymic organ culture [FTOC]) were performed. In general, Wnt3a−/− thymi were found to contain fewer thymocytes (usually about 3-fold lower) than Wt embryos, irrespective of the duration of culturing (data not shown). After 9 days of culturing, all stages of T-cell development could be distinguished, including mature single positive (SP) CD4+ and CD8+ cells, both in Wt and Wnt3a−/− embryos (Figure 5E). At this time point, no differences were detected in subset distribution between Wt and Wnt3a−/− thymi. However, when thymic lobes were cultured for prolonged times (14-17 days), T-cell development in Wnt3a−/− thymi rapidly deteriorated. This presented mainly as a decrease in the percentage of double-positive (DP) cells and an accumulation of CD8+ thymocytes, revealing a block at the ISP stage (Figure 5E). The progressively impaired T-cell development at the ISP stage phenocopies mice deficient in Tcf1,30 suggesting that the Wnt3a effects on immature thymocytes are mediated by signaling through Tcf1. To investigate whether this defect is intrinsic to the hematopoietic cells that seeded the thymus, we cultured Wt and Wnt3a−/− E12.5 FL cells in irradiated thymic lobes from Wt E14.5 embryos. After 14 to 21 days of culture, lobes were stained for flow cytometry. No differences were observed between FTOCs using Wt or Wnt3a−/− FL cells, with respect to cell numbers or thymocyte subset distribution (data not shown). The reduced T-cell development in Wnt3a−/− embryos must therefore be attributed to absence of Wnt3a production by the thymic stroma.
Wnt3a deficiency does not alter survival or cell cycle of hematopoietic stem and progenitor cells
Wnt3a−/− HSCs have impaired long-term repopulation capacity but have largely retained the ability to develop into all hematopoietic lineages. We next sought to study the cellular basis underlying this self-renewal defect.
HSC function depends on a tight regulation of the cell cycle. It was recently shown that activation of β-catenin leads to an increased proliferation followed by loss of stem cell activity and exhaustion of the HSC pool.8,9 We therefore analyzed the cell-cycle status of the HSC compartment. A high proportion of the LSK cells in the Wt FL are in cycle22 in agreement with FL being an organ where expansion of the HSC compartment occurs. No significant differences were found in the frequency of LSK cells in S/G2/M suggesting that Wnt3a deficiency has no effect on the HSCs proliferation (Figure 6A). Furthermore, to investigate whether LSKs from Wnt3a−/− embryos have decreased survival capacity, we analyzed apoptosis in these cells. In Wt and Wnt3a−/− LSK compartments, the frequency of annexin V+ cells did not differ (Figure 6B) indicating comparable apoptosis levels.
We also wanted to analyze whether Wnt3a deficiency differentially affected activation of the Notch-signaling pathway because this has been shown to be important for HSC function and has been proposed to collaborate with Wnt signaling to maintain stem cell properties.31 However using a specific antibody against activated Notch1 no differences were detected in the activation of this pathway in Wnt3a−/− comparing to Wt LSKs (Figure 6C).
Thus, neither alteration in cell cycle nor in survival of stem/progenitor cells explains the reduced numbers of cells and decreased long-term repopulation capacity. Furthermore, differential activation of Notch1 was also not observed.
Using a mouse model that lacks expression of Wnt3a, we show here that the deficiency of one specific Wnt protein leads to markedly reduced numbers of HSCs in vivo. These HSCs were not affected in multilineage differentiation potential but they had an irreversible and severely decreased self-renewal and long-term repopulation capacity, as determined by secondary transplantation assays. The absence of Wnt3a also strongly affects the primitive MPP progenitors and more mature myeloid progenitors such as CMPs and GMPs that were decreased in number. By contrast CLPs and precursor B cells were not affected.
Because MPPs retain both myeloid and lymphoid potentials but little or no erythroid-megakaryocyte potential,24,32,33 one could expect both myeloid and lymphoid progenitors to be affected. The fact that CMPs are severely reduced while CLP appeared not to be affected shows a stronger dependency on Wnt3a for myeloid versus B-lymphoid development. This is also supported by the strict dependence on Wnt–β-catenin signaling for the progression of chronic myelogenous leukemias whereas B-cell acute lymphoblastic leukemias can develop independently of β-catenin expression.13 Despite this deficiency at the progenitor level, mature myeloid cells were present at normal numbers. This can be explained by the fact that the defects observed do not completely block differentiation and because lineage-specific progenitors can probably compensate for the early incomplete differentiation block by rapid and extensive proliferation supported by cytokines that act in a lineage specific fashion, such as GM-, G- and M-CSF, as well as IL-7.
By means of coculture of FL progenitors with a BM derived stromal cell line, no defects in B-cell development were observed. It was previously shown that B-cell development in Lef1−/− mice is partially blocked at the pro–B-cell stage due to lack of Wnt- dependent proliferation.16 In agreement with this, Wnt5a was shown to negatively regulate proliferation of early B cells, possibly by inhibiting canonical-Wnt target genes.34 Although recombinant Wnt3a was shown to induce this proliferation in vitro,16 it is likely that Wnt3a is not the physiologically relevant Wnt for pro–B-cell proliferation or other Wnt proteins are compensating this function, as our data do not show a block in B-cell development. This is consistent with the idea that HSCs and precursor B cells occupy different niches.
In contrast, the T-cell lineage shows clear defects, probably reflecting the dependency of the early thymic emigrants on MPP as a major physiological precursor cell to the first cell that seeds the thymus.35 The progressively impaired T-cell development at the ISP stage observed phenocopies mice deficient in Tcf130 suggesting that in these mice T-cell development is blocked because of lack of a nuclear response to proliferative Wnt signals, as has also been suggested by previous loss-36,37 and gain-of-function studies.38 This phenotype appears to be environmentally determined, because Wnt3a−/− cells develop normally in Wt FTOCs. This is supported by the expression of Wnt3a in thymic epithelium, but not in the developing thymocytes.17 The similarities with Tcf1 deficiency suggest that Wnt3a is directly regulating thymocyte development, but it is possible that Wnt3a is also important for the thymic stroma and consequently affects T-cell development. Nevertheless, there appears to be an important difference in the function of Wnt3a for immature thymocytes, where it seems to be mainly a proliferation factor, versus HSCs where it influences self-renewal and differentiation cell fates
The Wnt3a deficiency does not only lead to a quantitative defect in HSC numbers, but Wnt3a−/− HSCs are also functionally affected. Although they are able to efficiently repopulate lethally irradiated primary recipients, long-term reconstitution capacity is markedly reduced when HSCs are rechallenged by transplantation into secondary recipient mice, demonstrating a lack in self-renewal capacity.
Because Wnt3a is a secreted factor it might affect HSCs directly or indirectly by signaling through the stromal cells39 that constitute the HSC niche. Thus, this environmentally determined deficiency turns into a cell-autonomous defect as Wnt3a in BM of the Wt recipient mice is not able to restore normal HSC function. This indicates that lack of Wnt3a during a critical period in embryonic development irreversibly impairs the self-renewal capacity of HSCs, suggesting that Wnt3a is important for the establishment of a specific genetic program in HSCs. A similar phenotype was observed in adult HSCs when they transiently occupied a niche that overexpressed the Wnt inhibitor Dkk1.40 Furthermore, the increased B-cell proliferation observed in Wnt5a-deficient FLs also could not be complemented by physiologic levels of Wnt5a expressed by Wt BM stroma.34 The irreversible Wnt3a−/− phenotype could possibly be explained by epigenetic alterations induced by Wnt signals. Indeed, different members of the Polycomb complex factors were shown to be essential for HSCs function.41,42 More specifically, Rae28 deficiency results in reduced fetal HSC and progenitor numbers, while FL cellularity and mature cell subsets remained unaffected,42 similarly to what we observed here.
Several lines of evidence suggest that Wnt activity is context dependent. Wnt proteins have different effects depending on the target cell,34 receptor availability,43 and probably other signals or pathways activated at the same time.6,44 In this way, approaches to generally activate or ablate Wnt signaling may lose the regulatory mechanisms between different Wnts. Indeed different β-catenin gain-of-function studies yielded different results probably reflecting the effect of different dosages of activation of the pathway.6,8,9 The notion that correct levels of Wnt signaling are critical in inducing a self-renewal type of expansion in HSC45 is also supported by experiments from Baba et al,46,47 who showed that it is possible to induce some stem cell characteristics in committed progenitors by ectopic expression of stable β-catenin. However, such progenitors did not reconstitute T cells when transplanted to immunodeficient mice, showing again that a very strong signal that bypasses all negative regulatory steps of the Wnt-signaling cascade such as given by stabilized β-catenin cannot mimic events triggered by tightly regulated physiological Wnt signals. Although initial studies failed to show a phenotype in the absence of β-catenin,10-12 2 recent loss of function approaches by knocking out β-catenin13 or overexpressing Dkk1,40 thereby inhibiting canonical Wnt signaling, showed reduced self-renewal capacity of HSCs. Here we were able to point one specific Wnt protein in this function, at least during embryonic development.
The reduced number of HSC and reduced long-term repopulation capacity observed could not be explained by alterations in cell cycle or survival of stem/progenitor cells. In this way, HSCs from Wnt3a−/− embryos seem to be biased to a non–self-renewing type of division leading to depletion of the HSC pool. Several developmentally conserved signaling pathways, including Notch, Hedgehog and Smad pathways, appear to be important in the regulation of HSC function48 and may normally collaborate with Wnt signaling in establishing a self-renewal genetic program. One such candidate is Notch signaling. However the levels of activated Notch1 did not differ between Wt and Wnt3a−/− LSK cells, making it unlikely that Notch1 plays this role.
Interestingly, besides the similarities with Tcf1−/−Lef−/− embryos,18 the posterior patterning defects observed in the Wnt3a−/− embryos also resemble the ones described for the Sox17−/− embryos. Sox17 was recently shown to be a critical regulator of fetal HSCs maintenance. Deletion of Sox17 leads to increased levels of Dkk1 implying that it maintains fetal HSCs by promoting Wnt signaling.49
We and others4 did not find Wnt3a expression at detectable levels in the FL, probably because of Wnt3a expression is only present a very restricted subset of niche cells. Nevertheless, this might indicate that the deficiency we report here is determined earlier during the embryonic development or in extrahepatic HSC sources. Because the numbers of definitive HSCs in E12.5 FL results from the cumulative HSC activity from the aorta-gonad-mesonephros (AGM) region, yolk sac, and placenta,21,50 these tissues warrant future study.
Given the differences between fetal and adult hematopoiesis, it is also important to investigate whether Wnt3a plays similar roles in the self-renewal of BM HSC. In view of the fact that Wnt3a is expressed in BM,16 such a functional role would not be unexpected. Finding specific Wnt proteins that regulate hematopoietic stem cell fate may have important implications for in vitro manipulation and expansion of the HSC compartment for transplantation and gene therapy applications as well as for the understanding of cancer stem cells in hematologic malignancies.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.
The authors thank Prof Dr Leonor Parreira for useful discussions. The authors are grateful to Karin Pike-Overzet, Peter Ng, Tom Schonewille, and Martijn Brugman for helping with various experiments. Dr Terry Yamaguchi is gratefully acknowledged for providing Wnt3a−/− mice. Marieke Comans-Bitter is acknowledged for preparing the figures.
T.C.L. is supported by Fundação para a Ciência e a Tecnologia-Portugal. F.J.T.S. is supported in part by the Association of International Cancer Research (AICR).
Contribution: T.C.L. and F.W. designed and performed experiments and wrote the manuscript; B.A.E.N., M.R.M.B., E.F.E.d.H., T.N., and S.H. performed experiments; R.d.H. contributed essential analytical tools; J.J.M.v.D. wrote the manuscript; and F.J.T.S. designed experiments, wrote the manuscript, and supervised the project.
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Correspondence: Dr Frank J. T. Staal, PhD, Department of Immunology, Room Ee838, Erasmus University Medical Center, Rotterdam, The Netherlands; e-mail: firstname.lastname@example.org.